Severe Pneumonia Treated Succesfully with Levofloxacin and Oseltamivir During Flu Epidemic
Pınar Akın Kabalak1, Asım Esenkaya2
1Clinic of Chest Diseases, Düzce Atatürk State Hospital, Düzce, Turkey.
Abstract:
Viral pneumonia is an important cause of community acquired pneumonias (CAP). It's not only specific to childhood period. Although immunocompromised adults are susceptible; all young and healthy adults are at risk. Viral pneumonias are usually underestimated due to lack of diagnostic modalities so a clinician must be aware of. Co-infection of viruses and bacteria is not uncommon and can be mortal especially in a flu epidemic, therefore, in the absence of diagnostic tools initiating to anti-viral treatment without delay is important.
Insights
Viral pneumonia is a significant cause of community-acquired pneumonia (CAP) affecting all adults, not just children. Early antiviral treatment is crucial due to diagnostic limitations and potential for severe co-infections.
Area of Science:
- Infectious Diseases
- Pulmonology
- Virology
Background:
- Community-acquired pneumonia (CAP) is a major health concern.
- Viral pneumonia is a significant, often underestimated, cause of CAP.
- Risk extends beyond children and immunocompromised adults to healthy individuals.
Purpose of the Study:
- To highlight the prevalence and risks of viral pneumonia in adults.
- To emphasize the diagnostic challenges associated with viral CAP.
- To underscore the importance of prompt antiviral treatment.
Main Methods:
- Review of existing literature on viral pneumonia.
- Analysis of clinical presentations and diagnostic limitations.
- Discussion of co-infection risks and treatment strategies.
Main Results:
- Viral pneumonia affects diverse adult populations, including healthy individuals.
- Diagnostic modalities for viral pneumonia are often lacking or delayed.
- Bacterial and viral co-infections increase mortality risk, particularly during influenza epidemics.
Conclusions:
- Clinicians must maintain a high index of suspicion for viral pneumonia.
- Timely initiation of antiviral therapy is critical in suspected cases.
- Awareness of co-infection potential is vital for patient outcomes.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy